Literature DB >> 7878681

Effects of supplemental nutrition on lead-induced depression of growth and food consumption in weanling rats.

P B Hammond1, P A Succop.   

Abstract

The objective of this study was to determine whether growth-depressant effects of lead (Pb) could be prevented by preventing the accompanying depression of caloric intake from ad libitum food consumption by caloric supplementation. The animal used was the female weanling rat. Three experiments were performed in which progressively increasing levels of caloric supplementation were provided in order to attain a level of nutrition which would totally prevent growth depression from Pb exposure. Nutritional supplementation of Pb-exposed animals almost completely eliminated the Pb-induced depression of weight gains. We conclude that the deficit in growth due to Pb can be adequately explained on the basis of a primary effect on appetite, rather than being secondary to depression of proliferative responses of cells to growth factors, e.g., insulin-like growth factor I.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7878681     DOI: 10.1006/taap.1995.1049

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  3 in total

1.  Alteration in plasma corticosterone levels following long term oral administration of lead produces depression like symptoms in rats.

Authors:  Saida Haider; Sadia Saleem; Saiqa Tabassum; Saima Khaliq; Saima Shamim; Zehra Batool; Tahira Parveen; Qurat-ul-ain Inam; Darakhshan J Haleem
Journal:  Metab Brain Dis       Date:  2013-01-12       Impact factor: 3.584

2.  Effect of succimer on growth of preschool children with moderate blood lead levels.

Authors:  Karen E Peterson; Mikhail Salganik; Carla Campbell; George G Rhoads; Judith Rubin; Omer Berger; James H Ware; Walter Rogan
Journal:  Environ Health Perspect       Date:  2004-02       Impact factor: 9.031

Review 3.  Adolescent health and the environment.

Authors:  M S Golub
Journal:  Environ Health Perspect       Date:  2000-04       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.